JAMM Therapeutics

Systemic Lupus Erythematosus Treatment

Health Tech & Life Sciences
Non Active, Jul 2024 ceased to operate
Seed , Israel Founded 2019
LinkedIn
Last updated 2026-06-18
Total raised
—
Last: 2020-05
Stage
Seed
Founded
2019
Headcount
1-10
HQ
, Israel
Sector
Health Tech & Life Sciences

About

JAMM Therapeutics is a drug discovery company developing a novel treatment approach for systemic lupus erythematosus. The company is currently being established at the FutuRx biotech incubator.

Funding history · 1 round · — total

2020-05

Q&A

What is the primary focus of JAMM Therapeutics?
JAMM Therapeutics is a drug discovery company developing a novel treatment approach for systemic lupus erythematosus.
When was JAMM Therapeutics founded?
JAMM Therapeutics was founded in October 2019.
What is the current status of JAMM Therapeutics?
JAMM Therapeutics is currently inactive, having ceased operations in July 2024.
Where is JAMM Therapeutics headquartered?
JAMM Therapeutics is headquartered in Ness Ziona, Israel.
Which investors participated in JAMM Therapeutics' funding round in May 2020?
In May 2020, FutuRx and RMGP Biopharma Investment Fund participated in a funding round for JAMM Therapeutics.
What is the employee count for JAMM Therapeutics?
JAMM Therapeutics has an employee bucket range of 1-10 employees.
What sector does JAMM Therapeutics primarily operate in?
JAMM Therapeutics primarily operates in the Health Tech & Life Sciences sector.
What is the current product stage of JAMM Therapeutics?
JAMM Therapeutics' product is in the R&D stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

drug-discoverypharmaceuticalsautoimmune-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)